Evelo Biosciences is reinventing the world of immune-therapeutics by harnessing the power of benign bacteria types as medicinal delivery vectors, primarily via the gut. They asked us to create an animation that would appeal to investors and the general public alike, and explain how these beneficial bacteria interact with cells in the gut to deliver medicines.